Heather H. Cheng, Ph.D.
Affiliations: | 2005 | University of Washington, Seattle, Seattle, WA |
Area:
Microbiology Biology, Molecular Biology, Animal Physiology Biology, Veterinary Science BiologyGoogle:
"Heather Cheng"Parents
Sign in to add mentor| Julie Overbaugh | grad student | 2005 | University of Washington | |
| (Envelope and receptor determinants for infection by an immunodeficiency -associated feline leukemia virus.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Raychaudhuri R, Tuchayi AM, Low SK, et al. (2025) Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes. European Urology Oncology |
| Yu EY, Rumble RB, Agarwal N, et al. (2025) Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2402608 |
| Zacchi F, Abida W, Antonarakis ES, et al. (2024) Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer. European Urology Oncology |
| Gillessen S, Turco F, Davis ID, et al. (2024) Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). European Urology |
| Francini E, Agarwal N, Castro E, et al. (2024) Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review. European Urology |
| Leader AE, Rebbeck TR, Oh WK, et al. (2024) Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing. Bmc Public Health. 24: 2533 |
| Raychaudhuri R, DeJong M, Rettig M, et al. (2024) Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial. European Urology |
| Raychaudhuri R, Mo G, Tuchayi AM, et al. (2024) Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to Lu-PSMA-617: A Retrospective Multicenter Cohort Study. Jco Precision Oncology. 8: e2300634 |
| Schaeffer EM, Srinivas S, Adra N, et al. (2024) Prostate Cancer, Version 3.2024. Journal of the National Comprehensive Cancer Network : Jnccn. 22: 140-150 |
| Parikh M, Tangen C, Hussain MHA, et al. (2024) Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide. European Urology Oncology |